Found 5 matching trials
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
PHASE2To study the pharmacokinetic profile of the therapeutic schedule in order t...
Location
Ospedale Pietrantoni
Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer
PHASE2To evaluate the efficacy and safety of treatment with MYOCET® (doxorubicin ...
Location
Teva Investigational Site 16
Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer
PHASE2This is an open phase II study evaluating the efficacy and safety of the no...
Location
Ziekenhuis Rijnstate
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
PHASE1This is an open-label study to assess the efficacy and tolerability of the ...
Location
Hospital Universitario Virgen de los Lirios
A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer
PHASE2It is a multicenter, open-label, two stage phase II trial, to assess activi...
Location
IRST Oncologia medica